This review explores hypertension and obesity trends in Japan, suggesting nutrient taxation and labeling may improve public health.
Japan is an archipelago west of the Pacific Ocean, facing decades of dietary and lifestyle westernization and its physiological consequences. Much like many other countries, Japan is tackling the global trend of lifestyle-related problems. This paper aims to discuss the current demographics in Japan and examine the origin and impact of lifestyle-related chronic diseases within the population. This review will highlight the nutritional transition during the country's development and examine the pathogenesis and pathophysiology of lifestyle-related diseases, primarily hypertension and obesity, in the context of traditional practices and cultural shifts. A combination of high salt intake in traditional cuisine and increased fat and sugar consumption from the westernization of the diet contributes to elevated blood pressures and obesity rates in Japan. This paper explores policy-based interventions, such as nutrient taxation and front-of-package labeling (FOPL), and their potential to mitigate these growing health concerns. One strategy is a nutrient tax to reduce the appeal of specific unhealthy products, such as sugar-sweetened beverages. Similarly, targeting alcohol with taxes and stricter regulations on advertising can reduce consumption. FOPL provides clear and concise nutritional information on the front of each product for consumers to make informed purchases. Expansion of blood pressure monitoring can allow patients to take a more proactive role in their own health, and providers can better tailor treatment plans. Increasing physical activity through workplace wellness programs can reduce the risk of chronic diseases and can be especially effective for Japanese office workers who tend to spend a lot of time in sedentary behavior. Collaboration amongst the government, businesses, and healthcare providers will be vital to empowering the general population to make healthy changes.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: